Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zeosys Medical
Luckenwalde, Brandenburg, Germany
- Ownership
- Private
- Development stage
- Other
01
Overview
ZeoSys Medical has developed and commercialised, via Baxter’s distribution network, a system that captures exhaled inhaled anaesthetic gases (desflurane, sevoflurane, isoflurane), adsorbs them on activated carbon in CONTRAfluran canisters, and enables later purification and reuse as active pharmaceutical ingredients, reducing environmental impact and facilitating a circular economy for inhaled anaesthesia in Europe[1][2].
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Surgical Medical Devices
02
Partnerships
Baxter
Beyond the preview
Go deeper on Zeosys Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zeosys Medical.